4′-Hydroxy-3′-methylacetophenone

We are 4′-Hydroxy-3′-methylacetophenone CAS:876-02-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 876-02-8
Product Name: 4'-Hydroxy-3'-methylacetophenone
Other Name:
4'-Hydroxy-3'-methylacetophenone
1-(4-Hydroxy-3-methylphenyl)ethanone
3'-methyl-4'-hydroxyacetophenone
4-hydroxy-5-methylacetophenone
4-hydroxy-3-methylphenyl methyl ketone
p-hydroxy-m-methylacetophenone
 
Density: 1.1±0.1 g/cm3
Boiling Point: 301.6±22.0 °C at 760 mmHg
Melting Point: 107-109 °C(lit.)
Molecular Formula: C9H10O2
Molecular Weight: 150.174
Flash Point: 127.3±14.9 °C
Exact Mass: 150.068085
PSA: 37.30000
LogP: 1.88
Vapour Pressure: 0.0±0.7 mmHg at 25°C
Index of Refraction: 1.546
 
Specification
Appearance: White to light beige crystalline powder
Assay: ≥99.0%
Dichloroacetyl chloride: ≤0.10%
Chloroacetyl chloride: ≤0.20%
Trichloroacetic acid: ≤0.20%
 
Application
Intermediates of Chlorpyrifos-methyl CAS: 5598-13-0.
Intermediates of Chlorpyrifos CAS: 2921-88-2.
Be used as pesticide intermediate, mainly used in the synthesis of insecticide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4'-Hydroxy-3'-methylacetophenone


Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.4-Amino-3-bromo-2-chloropyridine CAS:215364-85-5 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.2,2-dimethyl-6-nitro-4H-pyrido[3,2-b][1,4]oxazin-3-one CAS:1002726-59-1 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.3-Bromo-2-pyridinecarboxylic acid As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.The insulin-only and bihormonal configurations may be helpful in diabetes.

Related Products
Product Name
4-methylsulfanylbutan-2-one View Details
4-[4-Fluoro-3-(1-piperazinylcarbonyl)benzyl]-1(2H)-phthalazinone View Details
ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate View Details
3-Chloro-5-fluoropyridine manufacturer 7-fluoroheptan-1-ol manufacturer 2-Bromo-6-fluoroanisole manufacturer 1-(4-Bromophenyl)naphthalene manufacturer Vinylmethyldimethoxysilane manufacturer